Search Results

BioForest

EMulate Therapeutics Announces the Publication of the Evaluation of Its Ultra-Low Radiofrequency Energy Device in Murine Model of Glioblastoma in BMC Bioelectric Medicine

EMulate Therapeutics, Inc. (EMulate) announces the peer-reviewed publication titled, “Evaluation of the EMulate Therapeutics’ Ultra-Low Radiofrequency Energy (ulRFE®) Device in Murine Model of Glioblastoma (GBM)” in BMC Bioelectronic Medicine.

April 11, 2024

·

5 min read

Press Releases

Sequential Nested Trial Emulation Presented by Real-World Evidence Leader Target RWE at ISPE 2024

August 21, 2024

·

2 min read

Drug Development

EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager™ System in Patients with Recurrent Glioblastoma”

EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma in the Journal CNS Oncology https://www.futuremedicine.com/doi/10.2217/cns-2022-0016.

July 18, 2023

·

5 min read

BioForest

EMulate Therapeutics Inc. Announces Publication of Clinical Results at the SNO 2023 Conference: GBM and DIPG

EMulate Therapeutics, Inc. (EMTx) proudly announced today the acceptance of their abstract for presentation and publication in the 28th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 2023, in Vancouver, British Columbia.

November 14, 2023

·

5 min read

U.S. Capitol surrounded by money and pill bottles/Taylor Tieden for BioSpace

Opinion

Don’t Import Bad Policy Ideas on Drug Pricing

Suggestions that the U.S. should emulate other countries on drug price controls or patents obscure how our present policies have allowed drug development to flourish.

November 13, 2024

·

4 min read

·

Kirsten Axelsen

Genetown

Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets

Emulate, Inc., the leading provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.

June 26, 2023

·

5 min read

BioForest

EMulate Therapeutics Inc. (EMTx) Announces Company Presentation at Life Sciences Innovation North-West 2023

EMulate Therapeutics announced that Chris Rivera will present an overview of current results and future plans for EMTx at the Life Science Innovation Northwest 2023.

April 18, 2023

·

5 min read

Business

EMulate Therapeutics Announces the Addition of Donna Morgan Murray, Ph.D., to its Board of Directors

EMulate Therapeutics, Inc. today announced the addition of Donna Morgan Murray, Ph.D. to the Company’s board of directors.

March 14, 2023

·

5 min read

Genetown

Emulate Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

Emulate, Inc., a leading provider of next-generation in vitro models, announced that it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023.

March 2, 2023

·

4 min read

Business

EMulate Therapeutics Forms Technology Advisory Committee to Promote Growth and Innovation

EMulate Therapeutics today announced the formation of a new technology advisory committee that will bring expertise across multiple disciplines to facilitate company growth and innovation.

October 3, 2022

·

5 min read